Literature DB >> 34464879

Changes in LASSI-L performance over time among older adults with amnestic MCI and amyloid positivity: A preliminary study.

Marcela Kitaigorodsky1, Rosie E Curiel Cid2, Elizabeth Crocco2, Katherine L Gorman2, Christian J González-Jiménez2, Maria Greig-Custo3, Warren W Barker3, Ranjan Duara3, David A Loewenstein4.   

Abstract

There is a pressing need to develop measures that are sensitive to the earliest subtle cognitive changes of Alzheimer's disease (AD) to improve early detection and track disease progression. The Loewenstein-Acevedo Scales of Semantic Interference (LASSI-L) has been shown to successfully discriminate between cognitively unimpaired (CU) older adults and those with amnestic mild cognitive impairment (MCI) and to correlate with total and regional brain amyloid load. The present study investigated how the LASSI-L scores change over time among three distinct diagnostic groups. Eighty-six community-dwelling older adults underwent a baseline evaluation including: a clinical interview, a neuropsychological evaluation, Magnetic Resonance Imaging (MRI), and amyloid Positron Emission Tomography (PET). A follow up evaluation was conducted 12 months later. Initial mean values were calculated using one-way ANOVAs and chi-square analyses. Post-hoc comparisons were conducted using Tukey's Honestly Significant Difference (HSD). A 3 × 2 repeated measures analysis was utilized to examine differences in LASSI-L performance over time. The MCI amyloid positive group demonstrated a significantly greater decline in LASSI-L performance than the MCI amyloid negative and CU groups respectively. The scales that best differentiated the three groups included the Cued A2, which taps into maximum learning capacity, and Cued B2, which assesses the failure to recover from proactive semantic interference. Our findings further support the LASSI-L's discriminative validity.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Biomarkers; Cognitive outcome measures; Dementia; Mild cognitive impairment; Proactive semantic interference

Mesh:

Year:  2021        PMID: 34464879      PMCID: PMC8557121          DOI: 10.1016/j.jpsychires.2021.08.033

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  59 in total

1.  Short-term effect of dementia disclosure: how patients and families describe the diagnosis.

Authors:  Anna M Barrett; West Orange; Margaret Keller; Paula Damgaard; Russell H Swerdlow
Journal:  J Am Geriatr Soc       Date:  2006-12       Impact factor: 5.562

2.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.

Authors:  Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany
Journal:  Neuroimage       Date:  2006-03-10       Impact factor: 6.556

Review 3.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

Review 4.  Episodic memory in frontotemporal dementia: a critical review.

Authors:  Michael Hornberger; Olivier Piguet
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

5.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

6.  An investigation of PreMCI: subtypes and longitudinal outcomes.

Authors:  David A Loewenstein; Maria T Greig; John A Schinka; Warren Barker; Qian Shen; Elizabeth Potter; Ashok Raj; Larry Brooks; Daniel Varon; Michael Schoenberg; Jessica Banko; Huntington Potter; Ranjan Duara
Journal:  Alzheimers Dement       Date:  2012-05       Impact factor: 21.566

7.  Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.

Authors:  John Seibyl; Ana M Catafau; Henryk Barthel; Kenji Ishii; Christopher C Rowe; James B Leverenz; Bernardino Ghetti; James W Ironside; Masaki Takao; Hiroyasu Akatsu; Shigeo Murayama; Santiago Bullich; Andre Mueller; Norman Koglin; Walter J Schulz-Schaeffer; Anja Hoffmann; Marwan N Sabbagh; Andrew W Stephens; Osama Sabri
Journal:  J Nucl Med       Date:  2016-01-28       Impact factor: 10.057

8.  Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing.

Authors:  Claudia Bartels; Martin Wegrzyn; Anne Wiedl; Verena Ackermann; Hannelore Ehrenreich
Journal:  BMC Neurosci       Date:  2010-09-16       Impact factor: 3.288

9.  An overview of biomarkers in Alzheimer's disease.

Authors:  Pandurang R Wattamwar; P S Mathuranath
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

10.  Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials.

Authors:  Terry E Goldberg; Philip D Harvey; Keith A Wesnes; Peter J Snyder; Lon S Schneider
Journal:  Alzheimers Dement (Amst)       Date:  2015-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.